pretickt

Cardinal Health, Inc. (CAH)

Healthcare · end-of-day data as of Oct 16, 2026

Cardinal Health, Inc.
CAH · $58.83B
$254.06+11.7%last 60 sessions · close Oct 16, 2026
$151.84$254.0652 weeks
Buy · 17 analystsPT $265.38 +4.5%
  • P/E vs own+18.7%
  • P/E vs sector+24.8%
  • Target upside+4.5%
  • Off 52w high0.0%
  • Insiders-$59.55M
  • FCF yield+7.7%
  • Earnings in20d
  • Trendsideways
  • Sector▲ +16.0%
  • RSI74
  • MA20×50↑ in ~4d
  • Volume0.8x
  • Support-5.8%
  • Resistance—

The average 12-month analyst price target for CAH is $265.38, 4.5% above the last close of $254.06 on Oct 16, 2026; targets range from $217.94 to $295.41. Rating consensus: Buy.

Snapshot

  • P/E35.1x
  • P/E vs sector+24.8%
  • P/E vs own+18.7%
  • Target upside+4.5%
  • ConsensusBuy
  • Market cap$58.83B
  • FCF yield+7.7%
  • Insiders-$59.55M
  • Earnings in20d
  • News0.00

Why it moved

Cardinal Health, Inc. (CAH) rose 0.1% on Oct 16, 2026.

The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.

Market (SPY)-1.1%
Healthcare sector+0.4%
CAH specific+0.9%

0 stories on the day (30-day average 0.9).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Price and events

⇔⇕$158$188$218$247Oct 25Jan 26Apr 26Jul 26Oct 26EDAEDEDEDE

Last close $254.06 · +67.3% over 1y · E earnings · D dividend · S split · A analyst rating change

Technicals

  • Trendsideways
  • Sector▲ +16.0%
  • MAs20▲ 50▲ 100▲ 200▲
  • Above MAs4 of 4 above
  • MA20×50↑ in ~4d
  • RSI74
  • Support-5.8%
  • Resistance—
  • Off 52w high0.0%
  • Off ATH0.0%
  • 52w range$254.06
  • Bollingerabove upper
  • MACD3.03
  • ATR+2.3%
  • Volume0.8x

Analyst price targets

Low$217.94
Average$265.38
Median$267.89
High$295.41
Upside+4.5%

10 firms with a target in the last 12 months · last close $254.06 · as of Oct 16, 2026

⇔⇕$145$184$224$263$303Oct 25Mar 26Aug 26Jan 27Jun 27-13%-2%-4%+6%+16%
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets

Strong buy 3 · Buy 11 · Hold 3 · Sell 0 · Strong sell 0

Revenue and free cash flow

Q4 FY2026: Revenue +6.1% year over year, free cash flow 2.2% of revenue, operating margin 1.1%.

RevenueFree cash flow
Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
Q4 FY2026Jun 30, 2026$63.86B1.69$1.43B4.3%1.1%0.6%
Q3 FY2026Mar 31, 2026$60.94B1.69$1.68B4.1%0.8%0.7%
Q2 FY2026Dec 31, 2025$65.44B1.97$555M3.4%1.1%0.7%
Q1 FY2026Sep 30, 2025$64.01B1.88$865M3.6%1.0%0.7%
Q4 FY2025Jun 30, 2025$60.16B1.00$1.29B3.7%0.7%0.4%
Q3 FY2025Mar 31, 2025$54.88B2.10$2.79B3.9%1.3%0.9%
Q2 FY2025Dec 31, 2024$55.26B1.65-$499M3.5%1.0%0.7%
Q1 FY2025Sep 30, 2024$52.28B1.70-$1.74B3.6%1.1%0.8%

Peers

20D
1MCKMcKesson Corporation$1,004.84+0.6%0.0%-1.5%26.9$117B
2CORCencora, Inc.$340.92-0.1%-8.5%+6.8%25.3$65.06B
3BSXBoston Scientific Corporation$44.39+0.6%-57.7%+50.1%18.0$64.33B
4CAHCardinal Health, Inc.$254.06+0.1%0.0%+4.5%35.1$58.83B
5BDXBecton, Dickinson and Company$191.75-1.0%-1.0%-6.2%57.8$52.23B
6EWEdwards Lifesciences Corporation$86.60-1.7%-9.0%+15.2%49.8$49.9B
7HUMHumana Inc.$413.16-4.4%-4.7%+15.7%39.1$49.63B
8HSICHenry Schein, Inc.$86.38-0.7%-4.9%+6.0%25.2$9.63B

Data as of Oct 16, 2026 close.

Latest news

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.